Date: Tuesday, June 14, 2016
Session Time: 6:00pm-7:00pm
Presentation Time: 6:00pm-7:00pm
Location: Halls C&D
US Organ Procurement System known as one of the most advanced systems all over the World. Start of new transplant program in other country always brings a question – are OPTN/UNOS Policies applicable to another country's healthcare system?
Samara Region in Russia is a big region at Middle Volga about 3,2 million population. Transplant program starts here in 2005. First years of Samara Organ Procurement Center lets provide such results as 8 donors per million population with 2,3 organ per donor rate. 25% of all deceased donors were brain dead, all of the rest – are DCD. This values are common for Russia but we cant call them satisfactory.
So deep population analysis have been performed. For virtualisation we use 14TFlops high-performance cluster. Main differences between US and Russian healthcare backgrounds are: different ethnicity structure, other DCD quality (in Russia there are no Maastricht III DCD's), other transmissive infections background (Russian law dont let use organs from HCV and Lues positive donors). Analysing prognostic factors for kidney transplantation outcome we found that KDPI/KDRI criteria are significant for Russian population but numeric indexes needs to be corrected.
We also put some corrections in allocation criteria. They were necessary because there are no so much highly sencitized patients. Lack of assist devices bring us to perform transplant surgery earlier in heart and liver wait lists. Treatment protocols and donor management goals can be used in Russia without any changes.
This results help us to create a Clinical Donor Management Protocol on the base of OPTN/UNOS Policies. We put it for the base of Decision Support System. Transplant and surgery coordinators are using this system for they work.
Last two years using of OPTN/UNOS-based Decision Support System let us change results to 12 donor per million people and to 3,2 organ per donor rate. Weop decrease graft loss ant our costs for organ procurement.
Such results convince us that OPTN/UNOS-based policies are applicable in other countries even with diferent healthcare model. This can give us an opportunity to discuss worldwide organ procurement initiative given time.
CITATION INFORMATION: Yaremin B, Mironov A, Kolsanov A, Navasardyan A, Akhmetshin R, Starostina A. Can OPTN/UNOS Policies Be Effectively Transferred to Another Country's Healthcare System? Russian Case. Am J Transplant. 2016;16 (suppl 3).
To cite this abstract in AMA style:Yaremin B, Mironov A, Kolsanov A, Navasardyan A, Akhmetshin R, Starostina A. Can OPTN/UNOS Policies Be Effectively Transferred to Another Country's Healthcare System? Russian Case. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/can-optnunos-policies-be-effectively-transferred-to-another-countrys-healthcare-system-russian-case/. Accessed March 31, 2020.
« Back to 2016 American Transplant Congress